dulaglutide and semaglutide versus once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial what is the difference between

As a result, it may offer a uniquely versatile option for individuals with overlapping eating disorders, obesity, and SUDs

How will your dosing be adjusted

Wegovy mimics a single hunger hormone called GLP-1, whilst Mounjaro mimics two hormones: GLP-1 and GIP

Fermentable fibers can raise the bodys own GLP-1 through short-chain fatty acid signaling and improve satiety and glucose control, but their standalone weight-loss effect is small, on the order of 0.3 to 0.8 kg versus control, compared with 10 to 20 kg or more for the drugs

In a clinical trial where neither the participants nor the researchers knew who received the actual drug or a fake pill (placebo), 314492 adults who were overweight or obese (with an average body mass index of 36.2) were randomly assigned to take either lorcaserin (10 mg) or placebo twice a day for 52 weeks